Becton Dickinson And Company (BDX)
NYSE:BDX

Becton Dickinson (BDX) Stock Price & Analysis

1,557 Followers

BDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$214.27 - $266.70
Previous Close$241.12
Volume840.26K
Average Volume (3M)1.06M
Market Cap
$68.48B
Enterprise Value$84.63B
Total Cash (Recent Filing)$2.07B
Total Debt (Recent Filing)$18.22B
Price to Earnings (P/E)44.4
Beta0.58
Aug 03, 2023
3.6 (1.49%)
Share Statistics
EPS (TTM)5.44
Shares Outstanding284,014,905
10 Day Avg. Volume1,058,196
30 Day Avg. Volume1,056,476
Standard Deviation0.06
R-Squared0.24
Alpha0.00010
Financial Highlights & Ratios
Price to Book (P/B)196.76
Price to Sales (P/S)14.21
Price to Cash Flow (P/CF)94.10
P/FCF Ratio60.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.50
Enterprise Value/Gross Profit10.22
Enterprise Value/Ebitda19.22
Forecast
Price Target Upside17.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10


Financials

Annual

Risk Analysis

Main Risk Category
Macro & PoliticalRisks related to catastrophic events or geopolitical conditions that may disrupt the company’s business

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

BDX FAQ

What was Becton Dickinson And Company’s price range in the past 12 months?
Becton Dickinson And Company lowest stock price was $214.27 and its highest was $266.70 in the past 12 months.
    What is Becton Dickinson And Company’s market cap?
    Currently, no data Available
    When is Becton Dickinson And Company’s upcoming earnings report date?
    Becton Dickinson And Company’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
      How were Becton Dickinson And Company’s earnings last quarter?
      Becton Dickinson And Company released its earnings results on May 04, 2023. The company reported $2.86 earnings per share for the quarter, beating the consensus estimate of $2.743 by $0.117.
        Is Becton Dickinson And Company overvalued?
        According to Wall Street analysts Becton Dickinson And Company’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Becton Dickinson And Company pay dividends?
          Becton Dickinson And Company pays a Quarterly dividend of $0.91 which represents an annual dividend yield of 1.47%. See more information on Becton Dickinson And Company dividends here
            What is Becton Dickinson And Company’s EPS estimate?
            Becton Dickinson And Company’s EPS estimate is $2.9.
              How many shares outstanding does Becton Dickinson And Company have?
              Becton Dickinson And Company has 284,014,900 shares outstanding.
                What happened to Becton Dickinson And Company’s price movement after its last earnings report?
                Becton Dickinson And Company reported an EPS of $2.86 in its last earnings report, beating expectations of $2.743. Following the earnings report the stock price went down -4.23%.
                  Which hedge fund is a major shareholder of Becton Dickinson And Company?
                  Among the largest hedge funds holding Becton Dickinson And Company’s share is Longview Partners (Guernsey) Ltd. It holds Becton Dickinson And Company’s shares valued at 582M.

                    ---

                    Becton Dickinson Stock Smart Score

                    The Becton Dickinson stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Becton Dickinson And Company

                    Founded in 1897, Becton, Dickinson & Co. is a New Jersey-based medical technology company. The company develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional.

                    ---

                    Top 5 ETFs holding BDX

                    Name
                    Market Value
                    Smart Score
                    Vanguard S&P 500 ETF
                    $1.64B
                    8
                    SPDR S&P 500 ETF Trust
                    $770.83M
                    8
                    SPDR S&P 500 ETF Trust CDI
                    $761.16M
                    8
                    iShares Core S&P 500 ETF
                    $607.65M
                    8
                    Health Care Select Sector SPDR Fund
                    $569.11M
                    8
                    Up to five ETFs with an Outperform Smart Score that hold BDX. The ETFs are listed according to market value of BDX within the ETF

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Abbott Labs
                    Intuitive Surgical
                    Stryker
                    Boston Scientific

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis